Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of Inactivated Rotavirus Vaccine (Vero Cell) in Healthy Population
NCT04626856Phase 1Unknown
- Sponsor
- Chinese Academy of Medical Sciences
- Start
- Dec 2020
- Primary completion
- Jun 2021
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of Inactivated rotavirus vaccine in rotavirus infection, sponsored by Chinese Academy of Medical Sciences. Primary endpoints: Incidence of adverse reactions/events, Incidence of abnormal blood biochemistry, blood routine, and urine routine assessment and 1 more. Status: unknown.
02
Drugs
Inactivated rotavirus vaccine
03
Conditions
rotavirus infection
Beyond the preview
Go deeper on NCT04626856.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04626856.